Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MNMaheshi N RamasamyAMAngela M MinassianKJKatie J EwerALAmy L FlaxmanPMPedro M Folegatti
Jenner Institute · University of Oxford · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,404
total citations
- FWCI
- 31.76
- Percentile
- 100%
- References
- 24
Citations per year
Authors
421- MNMaheshi N RamasamyCorresponding
- AMAngela M Minassian
Jenner Institute, University of Oxford
- KJKatie J Ewer
University of Oxford, Jenner Institute
- ALAmy L Flaxman
Jenner Institute, University of Oxford
- PMPedro M Folegatti
Jenner Institute, University of Oxford
Topics & keywords
Topics
Keywords
- Immunogenicity
- Regimen
- Clinical trial
- Preparedness
- Vaccination
- Clinical research
- MEDLINE
- Public health
No related works found for this paper.
Funding
- URUK Research and InnovationAward: MC_PC_19055
- CFCoalition for Epidemic Preparedness Innovations
- NINational Institute for Health and Care Research
- MRMedical Research CouncilAwards: MR/T001151/1, MC_UU_00008/11, MR/L018942/1
- EAEngineering and Physical Sciences Research CouncilAwards: EP/R013756/1, EP/R013756/1